Walvax Biotechnology Co Ltd

Common Name
Walvax Biotechnology
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,388
Ticker
300142
Exchange
SHENZHEN STOCK EXCHANGE
Description
Walvax Biotechnology Co., Ltd. is a leading biopharmaceutical company based in China, focusing on the research, development, and commercialization of vaccines and biopharmaceutical products. Establish...

Walvax Biotechnology's GHG Emissions Data Preview

In 2024, Walvax Biotechnology completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Walvax Biotechnology has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Walvax Biotechnology’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Walvax Biotechnology’s data sources below and access millions more through our Disclosure Search.

a. Walvax Biotechnology's Sustainability Report 2024
a. Walvax Biotechnology's Sustainability Report 2024

Insights into Walvax Biotechnology's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Walvax Biotechnology amounted to 42,502.27 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Walvax Biotechnology decreased by 7.63%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Walvax Biotechnology's Scope 1 Emissions Over Time

20222023202403 k6 k9 k12 ktCO2e-8%-26%
  • Total Scope 1
  • Year-over-Year Change

What are Walvax Biotechnology's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Walvax Biotechnology were 7,643.23 metric tons of CO₂ equivalent (tCO₂e). a

Has Walvax Biotechnology reduced its Scope 1 emissions over time?

Since 2022, Walvax Biotechnology's Scope 1 emissions have decreased by 32.29%, reflecting a declining long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2023), Walvax Biotechnology's Scope 1 emissions decreased by 26.02%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Walvax Biotechnology's Scope 2 emissions?

In 2024, Walvax Biotechnology reported Scope 2 greenhouse gas (GHG) emissions of 34,859.04 tCO₂e without specifying the calculation method. a

Has Walvax Biotechnology reduced its Scope 2 emissions over time?

Since 2022, Walvax Biotechnology's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 16.63%, reflecting a rising long-term trend in Scope 2 emissions over time. a

Compared to the previous year (2023), Walvax Biotechnology's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Walvax Biotechnology 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Walvax Biotechnology use for Scope 2 reporting?

In 2024, Walvax Biotechnology reported its Scope 2 emissions using an unspecified methodology. a

Walvax Biotechnology's Scope 2 Emissions Over Time

20222023202409 k18 k27 k36 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Walvax Biotechnology’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Walvax Biotechnology reported Scope 1 greenhouse gas (GHG) emissions of 7,643.23 tCO₂e and total revenues of USD 387 millions. This translates into an emissions intensity of 19.77 tCO₂e per millions USD. a

Walvax Biotechnology's Scope 1 Emissions Intensity Compared to Peers

102002,00050,000500,000Scope 1 Emissions (tCO2e)5502002,00010,000Revenues (Millions of USD)CCHPDSDCCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MHumanwell Healthcare GroupYear: 2023Scope 1: 23,403 tCO2eRevenue: $M 3,451Scope 1 Intensity: 6.78 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,830Scope 1 Intensity: 7.19 tCO2e/$MHHHuadong MedicineYear: 2023Scope 1: 14,289 tCO2eRevenue: $M 5,716Scope 1 Intensity: 2.50 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYunnan Baiyao GroupYear: 2023Scope 1: 28,983 tCO2eRevenue: $M 5,503Scope 1 Intensity: 5.27 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MFosun PharmaYear: 2024Scope 1: 184,016 tCO2eRevenue: $M 5,627Scope 1 Intensity: 32.70 tCO2e/$MSSSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 286Scope 1 Intensity: 159.27 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MHua MedicineYear: 2023Scope 1: 19 tCO2eRevenue: $M 12Scope 1 Intensity: 1.63 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MMGI TechYear: 2023Scope 1: 18 tCO2eRevenue: $M 409Scope 1 Intensity: 0.04 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2023Scope 1: 46,854 tCO2eRevenue: $M 1,101Scope 1 Intensity: 42.55 tCO2e/$MCCChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$M

How does Walvax Biotechnology's GHG emissions intensity compare to its peers?

In 2024, Walvax Biotechnology reported a Scope 1 emissions intensity of 19.77 tCO₂e per millions USD. Compared to the peer group median of 30.05 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Walvax Biotechnology rank on GHG emissions intensity within its industry?

In 2024, Walvax Biotechnology ranked 11 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Walvax Biotechnology is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Walvax Biotechnology's GHG Emissions Dataset?
Sign Up